Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xifeng Tongluo Headache Tablets (熄风通络头痛片) is a traditional Chinese medicine (TCM) herbal product developed and marketed by Zhejiang H.Power Pharmaceutical. It is formulated as an oral tablet indicated for the treatment of headaches, particularly chronic cases, according to TCM principles. The formulation is designed to clear heat and toxic substances and improve circulation in the collaterals (tongluo) to alleviate pain. As a complex herbal mixture, its specific pharmacological mechanisms and molecular targets are not defined in the conventional Western pharmaceutical sense, but rather function through the synergistic effects of its constituent herbs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xifeng Tongluo Headache Tablets.